Skip to main content
. 2016 Dec 19;7(1):81–96. doi: 10.1007/s13555-016-0161-2

Fig. 7.

Fig. 7

Global assessment of efficacy by physician at each treatment visit (after 2, 4, 6, and 12 weeks) and 8 weeks after the end of treatment (intent-to-treat population). *P < 0.0001 (5-FU/SA vs. vehicle). 5-FU/SA 5-fluorouracil 0.5%/salicylic acid 10%